increase font size
Pause on J&J vaccine over clot reports will last only days, FDA says
The FDA issued a statement saying it recommends the pause 'out of an abundance of caution.'
By ZEKE MILLER, LAURAN NEERGAARD and MATTHEW PERRONEAssociated Press
Share
Johnson & Johnson vaccine is being distributed Saturday during a COVID-19 shot clinic hosted by Augusta Fire & Rescue at Cony Middle and High School in Augusta. Joe Phelan/Kennebec Journal
WASHINGTON — The U.S. is recommending a “pause” in using the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.
The Food and Drug Administration says it expects a short pause of Johnson & Johnson vaccines while regulators investigate reports of potentially dangerous clots in a small number of patients.